Central Trust CO Amarin Corp Plcuk Transaction History

Central Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$2.85 - $3.73 $570 - $746	-200 Closed	0 $0
Q2 2020 Jul 14, 2020	SELL	$4.78 - $8.26 $1,434 - $2,478	-300 Reduced 60.0%	200 $1,000
Q4 2019 Jan 21, 2020	BUY	$13.94 - $24.12 $2,788 - $4,824	200 Added 66.67%	500 $10,000
Q2 2019 Jul 12, 2019	BUY	$16.27 - $20.51 $4,881 - $6,153	300 New	300 $0

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.